Aptuit Announces Appointment of Timothy C. Tyson as Executive Chairman and CEO.GREENWICH, Conn. -- Aptuit, Inc. announced today that Timothy (Tim) C. Tyson, a 30-year pharmaceutical industry veteran, has been appointed Executive Chairman and acting CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . Michael A. Griffith, the company's founder and Chief Executive Officer since 2005, has resigned in order to pursue other opportunities. "The Board wishes to thank Mike for his outstanding success in creating a world-class organization that is a trusted partner to hundreds of innovative clients throughout the world," said Tony Ecock, outgoing Chairman of Aptuit's Board of Managers. "With 2,700 employees working with more than 800 clients throughout the world, Aptuit has established a solid foundation for continued growth and success." Aptuit's interim CEO, Tim Tyson, is the former COO (Cell Of Origin) See mobile positioning. , President and CEO of Valeant Pharmaceuticals International Valeant Pharmaceuticals International is a pharmaceutical company with activities spanning the drug discovery pipeline from target identification through clinical trials and commercialization. , where he served from 2002-2008. Prior to Valeant, Tyson's pharmaceutical industry experience includes a 14-year tenure at GlaxoSmithKline, where he was President of Global Manufacturing and Supply and ran Glaxo Dermatology dermatology (dûrmətŏl`əjē), branch of medicine concerned with diagnosis and treatment of diseases and disorders of the skin. and Cerenex Pharmaceuticals. There he managed all sales and marketing for GlaxoWellcome's U.S. operations. Tyson has also held executive positions at Bristol-Myers in commercial and technical operations and R&D. Previously he was a manufacturing manager for Procter & Gamble. "I am honored hon·or n. 1. High respect, as that shown for special merit; esteem: the honor shown to a Nobel laureate. 2. a. Good name; reputation. b. to have the opportunity to help lead the next phase of Aptuit's growth, and to build on the many achievements the company has had to date," Tyson said. "Aptuit is uniquely positioned to help innovative partners create the new medicines of tomorrow, and we will work tirelessly tire·less adj. Not yielding to fatigue; untiring or indefatigable. tire  less·ly adv. to ensure that we do all that we
can to help improve the way drugs are developed."
About Aptuit Aptuit, Inc. is a global company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators innovators people who will try new things. early innovators important figures in the farming or client community because they are the leaders in the introduction of new techniques and management systems. . The company was founded by a group of industry experts with extensive market experience who have a track record of building a similar, highly successful company through acquisitions and investment. Aptuit provides a comprehensive suite of product development services and competencies to more than 800 biotechnology and large, fully integrated pharmaceutical innovators worldwide. Aptuit's mission is to engineer a better drug development process, and is partnered with Welsh, Carson, Anderson Anderson, river, Canada Anderson, river, c.465 mi (750 km) long, rising in several lakes in N central Northwest Territories, Canada. It meanders north and west before receiving the Carnwath River and flowing north to Liverpool Bay, an arm of the Arctic & Stowe, one of the world's largest private equity investors. For more information about Aptuit, please visit www.aptuit.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion